← Back
Data updated: Mar 10, 2026
APPCO
GastroenterologyCardiovascular
APPCO is a generic drug manufacturer focused on Gastroenterology, Cardiovascular. Key products include TRANEXAMIC ACID.
2007
Since
19
Drugs
-
Trials
186
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
BUMETANIDE 2026-02-05
PRUCALOPRIDE SUCCINATE 2026-02-05
PRUCALOPRIDE SUCCINATE 2026-01-29
Labeling
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
TRANEXAMIC ACID 2026-01-26
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 67%
2 drugs
Cardiovascular 33%
1 drugs
Pipeline Strength Pro
Loading...
Active (7)
Discontinued (11)
Company Info
- First Approval
- 2007-02-06
- Latest
- 2026-01-20
- Applications
- 20